Showing results (71-80 of 102) with videos related to

Sort By:
Pageof 11
International Journal of Radiation Oncology, Biology, Physics|December 2, 2019
High-risk Meningioma: Initial Outcomes From NRG Oncology/RTOG 0539C Leland Rogers, Minhee Won, Michael A Vogelbaum, et al.
Inflammatory Bowel Diseases|April 21, 2015
Blood-based biomarkers used to predict disease activity in Crohn's disease and ulcerative colitisRobert Burakoff, Vikas Pabby, Louisa Onyewadume, et al.
Investigative Ophthalmology & Visual Science|November 24, 2006
Multiphoton fluorescence and second harmonic generation imaging of the structural alterations in keratoconus ex vivoHsin-Yuan Tan, Yen Sun, Wen Lo, et al.
Neuro-Oncology|November 5, 2025
Multicenter Randomized Phase II Study of R-MPV-A Chemoimmunotherapy With or Without Low-Dose Whole-Brain Radiotherapy for Newly-Diagnosed Primary CNS LymphomaAntonio Omuro, Lisa M DeAngelis, Mei-Yin C Polley, et al.
International Journal of Radiation Oncology, Biology, Physics|February 24, 2025
Boswellia Serrata for Cerebral Radiation Necrosis After Radiosurgery for Brain MetastasesRituraj Upadhyay, Ahmed Nader Mohammed Elguindy, Laura Salts, et al.
Neuro-Oncology|June 3, 2022
Low-risk meningioma: Initial outcomes from NRG Oncology/RTOG 0539C Leland Rogers, Stephanie L Pugh, Michael A Vogelbaum, et al.
International Journal of Radiation Oncology, Biology, Physics|April 7, 2020
Phase 2 Study of a Temozolomide-Based Chemoradiation Therapy Regimen for High-Risk, Low-Grade Gliomas: Long-Term Results of Radiation Therapy Oncology Group 0424Barbara J Fisher, Stephanie L Pugh, David R Macdonald, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2008
Novel blood-based, five-gene biomarker set for the detection of colorectal cancerMark Han, Choong Tsek Liew, Hong Wei Zhang, et al.
Brachytherapy|November 4, 2021
American Brachytherapy Society radiation oncology alternative payment model task force: Quality measures and metrics for brachytherapyChirag Shah, Frank Vicini, Sushil Beriwal, et al.
JCO Precision Oncology|September 30, 2021
Long-Term Report of a Comprehensive Molecular and Genomic Analysis in NRG Oncology/RTOG 0424: A Phase II Study of Radiation and Temozolomide in High-Risk Grade II GliomaJessica L Fleming, Stephanie L Pugh, Barbara J Fisher, et al.
Pageof 11